Terms: = Kidney tumors AND NR4A3, MINOR, 8013, ENSG00000119508, Q92570, CHN, NOR1, CSMF AND Prognosis
37 results:
1. Systematic review on oncologic outcomes on adjuvant endovesical treatment for non-muscle invasive bladder cancer in patients with solid organ transplant.
Simonet M; Dominguez Gutierrez A; Territo A; Prudhomme T; Campi R; Andras I; Baboudjian M; Hevia V; Boissier R;
World J Urol; 2022 Dec; 40(12):2901-2910. PubMed ID: 36367586
[TBL] [Abstract] [Full Text] [Related]
2. MicroRNA Signatures in the Upper Urinary Tract Urothelial Carcinoma Scenario: Ready for the Game Changer?
Cinque A; Capasso A; Vago R; Floris M; Lee MW; Minnei R; Trevisani F
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269744
[TBL] [Abstract] [Full Text] [Related]
3. Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes.
Tsai YC; Huang CY; Hsueh YM; Fan YC; Fong YC; Huang SP; Geng JH; Chen LC; Lu TL; Bao BY
Life Sci; 2021 Jun; 275():119396. PubMed ID: 33774030
[TBL] [Abstract] [Full Text] [Related]
4. Staging of renal cell carcinoma: current progress and potential advances.
Delahunt B; Eble JN; Samaratunga H; Thunders M; Yaxley JW; Egevad L
Pathology; 2021 Jan; 53(1):120-128. PubMed ID: 33121821
[TBL] [Abstract] [Full Text] [Related]
5. Clinical Spectrum of Uveal Metastasis in Korean Patients Based on Primary Tumor Origin.
Kang HG; Kim M; Byeon SH; Kim SS; Koh HJ; Lee SC; Kim M
Ophthalmol Retina; 2021 Jun; 5(6):543-552. PubMed ID: 32942025
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic score predicts overall survival following complete urinary tract extirpation.
Akand M; Muilwijk T; Van Der Aa F; Gevaert T; Milenkovic U; Moris L; Blyweert W; Van Poppel H; Albersen M; Joniau S
Scand J Urol; 2020 Feb; 54(1):70-79. PubMed ID: 31975650
[No Abstract] [Full Text] [Related]
7. Morbidity, perioperative outcomes and complications of robot-assisted radical prostatectomy in kidney transplant patients: A French multicentre study.
Felber M; Drouin SJ; Grande P; Vaessen C; Parra J; Barrou B; Matillon X; Crouzet S; Leclerc Q; Rigaud J; Prudhomme T; Doumerc N; Bergerat S; Lang H; Laine C; Robert G; Gobert A; Granger B; Rouprêt M
Urol Oncol; 2020 Jun; 38(6):599.e15-599.e21. PubMed ID: 31948931
[TBL] [Abstract] [Full Text] [Related]
8. Aggressive squamous cell carcinoma of the renal pelvis.
Kartal I; Uysal S; Adabag A; Gok A; Sagnak AL; Ersoy H
Niger J Clin Pract; 2019 Apr; 22(4):588-590. PubMed ID: 30975969
[TBL] [Abstract] [Full Text] [Related]
9. Acquired cystic disease-associated renal cell carcinoma is the most common subtype in long-term dialyzed patients: Central pathology results according to the 2016 WHO classification in a multi-institutional study.
Kondo T; Sasa N; Yamada H; Takagi T; Iizuka J; Kobayashi H; Yoshida K; Fukuda H; Ishihara H; Tanabe K; Tsuzuki T
Pathol Int; 2018 Oct; 68(10):543-549. PubMed ID: 30187581
[TBL] [Abstract] [Full Text] [Related]
10. [Pulmonary metastasectomy in renal cell carcinoma].
Macherey S; Kauffmann C; Heidenreich A; Doerr F; Wahlers T; Hekmat K
Urologe A; 2017 Aug; 56(8):1025-1030. PubMed ID: 28280862
[TBL] [Abstract] [Full Text] [Related]
11. Surgical and Oncologic Outcomes of Laparoscopic Radical Nephrectomy for Non-Metastatic Renal Cancer in Long-Term Dialysis Patients.
Omae K; Kondo T; Takagi T; Iizuka J; Kobayashi H; Hashimoto Y; Tanabe K
Ther Apher Dial; 2017 Feb; 21(1):31-37. PubMed ID: 28067459
[TBL] [Abstract] [Full Text] [Related]
12. The utility of tetraspanin CD9 as a biomarker for metastatic clear cell renal cell carcinoma.
Garner JM; Herr MJ; Hodges KB; Jennings LK
Biochem Biophys Res Commun; 2016 Feb; 471(1):21-5. PubMed ID: 26855131
[TBL] [Abstract] [Full Text] [Related]
13. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder.
Reis LO; Taheri D; Chaux A; Guner G; Mendoza Rodriguez MA; Bivalacqua TJ; Schoenberg MP; Epstein JI; Netto GJ
Hum Pathol; 2016 Jan; 47(1):20-5. PubMed ID: 26520419
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of MMP-9 using a pyrrole-imidazole polyamide reduces cell invasion in renal cell carcinoma.
Sato A; Nagase H; Obinata D; Fujiwara K; Fukuda N; Soma M; Yamaguchi K; Kawata N; Takahashi S
Int J Oncol; 2013 Nov; 43(5):1441-6. PubMed ID: 23969530
[TBL] [Abstract] [Full Text] [Related]
15. Hyalinizing clear cell carcinoma of the base of tongue: a distinct and rare entity.
Masilamani S; Rao S; Chirakkal P; Kumar AR
Indian J Pathol Microbiol; 2011; 54(1):167-9. PubMed ID: 21393908
[TBL] [Abstract] [Full Text] [Related]
16. A phase II study of the cancer vaccine TG4010 alone and in combination with cytokines in patients with metastatic renal clear-cell carcinoma: clinical and immunological findings.
Oudard S; Rixe O; Beuselinck B; Linassier C; Banu E; Machiels JP; Baudard M; Ringeisen F; Velu T; Lefrere-Belda MA; Limacher JM; Fridman WH; Azizi M; Acres B; Tartour E
Cancer Immunol Immunother; 2011 Feb; 60(2):261-71. PubMed ID: 21069322
[TBL] [Abstract] [Full Text] [Related]
17. Revisiting old slides--how worthwhile is it?
Agarwal S; Wadhwa N
Pathol Res Pract; 2010 Jun; 206(6):368-71. PubMed ID: 20188486
[TBL] [Abstract] [Full Text] [Related]
18. Second opinion pathology in tertiary care of patients with urologic malignancies.
Wayment RO; Bourne A; Kay P; Tarter TH
Urol Oncol; 2011; 29(2):194-8. PubMed ID: 19523859
[TBL] [Abstract] [Full Text] [Related]
19. Perioperative cardiovascular and noncardiovascular risk in patients with colorectal cancer.
Pernicky M; Murin J; Labas P
Bratisl Lek Listy; 2007; 108(6):246-50. PubMed ID: 17972534
[TBL] [Abstract] [Full Text] [Related]
20. Cystinyl aminopeptidase activity is decreased in renal cell carcinomas.
Larrinaga G; López JI; Casis L; Blanco L; Gil J; Agirregoitia E; Varona A
Regul Pept; 2007 Dec; 144(1-3):56-61. PubMed ID: 17692401
[TBL] [Abstract] [Full Text] [Related]
[Next]
